LDHA is the Key Enzyme for Lactate Production

LDHA catalyzes the reversible conversion of pyruvate to lactate, a critical step in cellular metabolism. Upon immune cell activation, glycolysis is upregulated and LDHA activity increases, promoting lactate production to support the metabolic demands of inflammation.
Lactate is not merely a metabolic byproduct but also a key inflammatory signaling molecule that modulates immune cell function. Elevated lactate levels potentiate inflammatory signaling pathways and influence immune cell differentiation, contributing to the persistence of chronic inflammation.
LDHA lies at the core of the immunometabolic network, serving as a key node linking lactate metabolism and inflammatory signaling. Given lactate’s role in regulating immune responses, LDHA represents a promising target for modulating inflammatory metabolism.

Glucose

Glucose

Immune Cell Activation State

Immune Cell Activation State

Pyruvate

Pyruvate

LDHA

LDHA

Lactate

Lactate

MP-5342: Targeting LDHA

MP-5342 is a first-in-class oral small molecule inhibitor of LDH, developed in-house by Meta Bio, that selectively inhibits lactate dehydrogenase activity. By blocking a key step in lactate production, MP-5342 interrupts the positive feedback loop of inflammatory signaling at the metabolic level and modulates immune cell function. This mechanism holds promise for controlling inflammation across multiple autoimmune diseases, including inflammatory bowel disease (IBD), and for restoring immune balance.
Innovation for Patients

Innovation for Patients

We Care

Unmet patient needs in chronic diseases.

We Advance

Immunometabolic innovation from discovery to clinical translation.

We Believe

Truly valuable medical innovation must ultimately serve real patient needs.